A coalition of companies and groups like the Bill & Melinda Gates Foundation and Amgen Inc. (NASDAQ:AMGN) with offices in Seattle and Bothell, are working together to produce more of the experimental Ebola drug ZMapp, Bloomberg reported on Friday. Amgen Inc. (NASDAQ:AMGN) belongs to Healthcare sector. Its net profit margin is 25.70% and weekly performance is 2.96%. On last trading day company shares ended up $137.51. Amgen Inc. (NASDAQ:AMGN) distance from 50-day simple moving average (SMA50) is 0.74%.

On Oct. 7, MagnaChip Semiconductor Corporation (NYSE:MX) announced that it has received an extension for continued listing and trading of the Company’s common stock on the New York Stock Exchange (the “NYSE”). MagnaChip Semiconductor Corporation (NYSE:MX) shares advanced 0.39% in last trading session and ended the day at $10.38. MagnaChip Semiconductor Corporation (NYSE:MX) quarterly performance is -28.27%.

Specialty pharmaceutical company Actavis plc (NYSE:ACT) is said to be among the bidders for Belgian consumer health-care company Omega Pharma NV as it continues to look for more acquisition, according to a Bloomberg report on Monday. A sale of Omega would likely fetch in excess of 4 billion euros or $5.1 billion. Actavis plc (NYSE:ACT) belongs to Healthcare sector. Its net profit margin is 0.60% and weekly performance is 1.74%. On last trading day company shares ended up $226.67. Actavis plc (NYSE:ACT) distance from 50-day simple moving average (SMA50) is -1.57%.

Zacks downgraded shares of Ducommun (NYSE:DCO) from an outperform rating to a neutral rating in a report issued on Tuesday. They currently have $34.40 target price on the stock. Ducommun Inc. (NYSE:DCO) ended the last trading day at $28.10. Company weekly volatility is calculated as 4.68% and price to cash ratio as 6.99. Ducommun Inc. (NYSE:DCO) showed a weekly performance of 4.34%.

Rubicon Project (NYSE:RUBI) has been named one of the 30 Best Places to Work in New York City Tech by Internet Week. Rubicon Project was among 30 companies selected based on criteria including hiring practices, benefits packages, salaries, office perks, workplace environment and design, and diversity policies, as well as surveys completed by over 2,000 employees at the finalist companies. the Rubicon Project, Inc. (NYSE:RUBI) shares decreased -0.10% in last trading session and ended the day at $10.01. RUBI Gross Margin is 82.60% and its return on assets is -13.50%. the Rubicon Project, Inc. (NYSE:RUBI) quarterly performance is 0.00%.